Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2026-02-20 @ 3:32 PM
Study NCT ID:
NCT01795703
Status:
COMPLETED
Last Update Posted:
2015-11-04
First Post:
2013-01-30
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Study to Evaluate Safety and Efficacy of Abiraterone in Participants With Prostate Cancer Who Have Received Docetaxel
Sponsor:
Janssen Research & Development, LLC
Organization: